Jain Global’s Protara Therapeutics TARA Stock Holding History

Jain Global’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,212	Closed	-$81.8K	–	1601
2025 Q1	$81.8K	Buy	+19,212	New	+$85.8K	﹤0.01%	979

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jain Global's TARA Position: Q2 2025 in Review

Jain Global sold out of Protara Therapeutics (TARA) in Q2 2025, closing a stake of 19,212 shares — an estimated $81.8K sold.

Jain Global first reported a position in TARA in Q1 2025 and held it in 1 quarter. The position peaked at $81.8K in Q1 2025. 76 funds tracked by Wall St. Rank hold TARA as of Q2 2025.

Jain Global reported no remaining Protara Therapeutics position as of Q2 2025 after selling out during the quarter.
Jain Global sold 19,212 Protara Therapeutics shares in Q2 2025, an estimated $81.8K.
Jain Global first reported a position in Protara Therapeutics in Q1 2025 and held it in 1 quarter.
Jain Global's Protara Therapeutics position peaked at $81.8K in Q1 2025.
76 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.